发明名称 2,4-Diaminopyrimidine derivatives
摘要 <p>There are provided compounds of formula I wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are as indicated in claim 1, useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.</p>
申请公布号 SI2308855(T1) 申请公布日期 2013.01.31
申请号 SI20030032226T 申请日期 2003.03.14
申请人 NOVARTIS AG 发明人 BAENTELI ROLF;ZENKE GERHARD;COOKE NIGEL GRAHAM;DUTHALER RUDOLF;THOMA GEBHARD;VON MATT ANETTE;HONDA TOSHIYUKI;MATSUURA NAOKO;NONOMURA KAZUHIKO;OHMORI OSAMU;UMEMURA ICHIRO;HINTERDING KLAUS;PAPAGEORGIOU CHRISTOS
分类号 A61K31/505;A61K31/506;A61K31/5377;A61K31/55;A61K31/635;A61K45/00;A61P1/04;A61P1/16;A61P3/10;A61P5/14;A61P9/04;A61P9/10;A61P9/12;A61P9/14;A61P11/00;A61P11/06;A61P11/16;A61P13/12;A61P17/00;A61P17/02;A61P17/06;A61P17/08;A61P19/02;A61P21/04;A61P25/00;A61P25/28;A61P27/02;A61P29/00;A61P31/00;A61P31/04;A61P31/18;A61P35/00;A61P35/02;A61P35/04;A61P37/00;A61P37/06;A61P43/00;C07D239/48;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D417/12;C07D521/00 主分类号 A61K31/505
代理机构 代理人
主权项
地址